Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.

Item

http://www.wikidata.org/entity/Q40373071

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Population-based experience on ...... : the incidence is increasing.

@en

type

Item

label

Population-based experience on ...... : the incidence is increasing.

@en

prefLabel

Population-based experience on ...... : the incidence is increasing.

@en

P1476

Population-based experience on ...... : the incidence is increasing.

@en

P2093

Christer Sundström

http://www.w3.org/2001/XMLSchema#string

Eva Baecklund

http://www.w3.org/2001/XMLSchema#string

Gunilla Enblad

http://www.w3.org/2001/XMLSchema#string

Gustaf Martinsson

http://www.w3.org/2001/XMLSchema#string

Göran Hesselager

http://www.w3.org/2001/XMLSchema#string

Hans Hagberg

http://www.w3.org/2001/XMLSchema#string

Rosie-Marie Amini

http://www.w3.org/2001/XMLSchema#string

P2860

Primary intraocular lymphoma

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.

Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.

The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma.

The epidemiology of thyroid disease.

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.

Advantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution.

P304

599-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2016.1270465

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28084866

http://www.w3.org/2001/XMLSchema#string